Barnett & Company’s Sanofi SNY Stock Holding History

Barnett & Company’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-258	Closed	-$14K	–	241
2021 Q2	$14K	Hold	258	–	–	0.01%	188
2021 Q1	$13K	Hold	258	–	–	0.01%	235
2020 Q4	$12K	Hold	258	–	–	0.01%	237
2020 Q3	$13K	Hold	258	–	–	0.01%	235
2020 Q2	$13K	Hold	258	–	–	0.01%	214
2020 Q1	$11K	Hold	258	–	–	0.01%	248
2019 Q4	$13K	Buy	258 +58	+29%	+$2.72K	0.01%	286
2019 Q3	$9K	Hold	200	–	–	0.01%	262
2019 Q2	$9K	Hold	200	–	–	0.01%	249
2019 Q1	$9K	Hold	200	–	–	0.01%	268
2018 Q4	$9K	Hold	200	–	–	0.01%	275
2018 Q3	$9K	Hold	200	–	–	﹤0.01%	304
2018 Q2	$8K	Buy	+200	New	+$7.87K	﹤0.01%	280
2016 Q4	–	Sell	-213	Closed	-$8K	–	399
2016 Q3	$8K	Buy	+213	New	+$8.55K	﹤0.01%	348

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Barnett & Company's SNY Position: Q3 2021 in Review

Barnett & Company sold out of Sanofi (SNY) in Q3 2021, closing a stake of 258 shares — an estimated $14K sold.

Barnett & Company first reported a position in SNY in Q3 2016 and held it in 14 quarters. The position peaked at $14K in Q2 2021. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

Barnett & Company reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
Barnett & Company sold 258 Sanofi shares in Q3 2021, an estimated $14K.
Barnett & Company first reported a position in Sanofi in Q3 2016 and held it in 14 quarters.
Barnett & Company's Sanofi position peaked at $14K in Q2 2021.
577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Barnett & Company's 13F filing for Q3 2021, filed 4 Nov 2021.